Clinical Trial Detail

NCT ID NCT03144661
Title An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

nasopharynx carcinoma

cholangiocarcinoma

esophageal cancer

hepatocellular carcinoma

ovarian serous carcinoma

Advanced Solid Tumor

Therapies

INCB062079

Age Groups: senior adult

No variant requirements are available.